Universal Scientific Industrial (Shanghai) Future Growth
Future criteria checks 2/6
Universal Scientific Industrial (Shanghai) is forecast to grow earnings and revenue by 22.5% and 8.3% per annum respectively. EPS is expected to grow by 22.1% per annum. Return on equity is forecast to be 16.1% in 3 years.
Key information
22.5%
Earnings growth rate
22.1%
EPS growth rate
| Electronic earnings growth | 29.0% |
| Revenue growth rate | 8.3% |
| Future return on equity | 16.1% |
| Analyst coverage | Good |
| Last updated | 03 Apr 2024 |
Recent future growth updates
Recent updates
Some Investors May Be Willing To Look Past Universal Scientific Industrial (Shanghai)'s (SHSE:601231) Soft Earnings
Apr 08
Earnings Miss: Universal Scientific Industrial (Shanghai) Co., Ltd. Missed EPS By 7.3% And Analysts Are Revising Their Forecasts
Apr 04Universal Scientific Industrial (Shanghai) Co., Ltd. (SHSE:601231) Stock Catapults 27% Though Its Price And Business Still Lag The Market
Mar 04Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 77,445 | 3,572 | N/A | N/A | 1 |
| 12/31/2025 | 72,638 | 3,295 | 2,608 | 4,131 | 6 |
| 12/31/2024 | 66,879 | 2,434 | 1,397 | 6,604 | 5 |
| 12/31/2023 | 60,792 | 1,948 | 5,274 | 6,823 | N/A |
| 9/30/2023 | 62,043 | 2,281 | 4,819 | 6,410 | N/A |
| 6/30/2023 | 66,441 | 2,743 | 5,628 | 7,149 | N/A |
| 3/31/2023 | 67,561 | 2,898 | 2,776 | 4,287 | N/A |
| 12/31/2022 | 68,516 | 3,060 | 1,764 | 3,435 | N/A |
| 9/30/2022 | 68,312 | 2,906 | 372 | 1,907 | N/A |
| 6/30/2022 | 61,967 | 2,392 | -2,132 | -433 | N/A |
| 3/31/2022 | 58,319 | 2,052 | -1,011 | 809 | N/A |
| 12/31/2021 | 55,300 | 1,858 | -2,617 | -1,102 | N/A |
| 9/30/2021 | 54,735 | 1,861 | -1,425 | -186 | N/A |
| 6/30/2021 | 52,952 | 1,785 | -453 | 690 | N/A |
| 3/31/2021 | 51,018 | 1,793 | -254 | 891 | N/A |
| 12/31/2020 | 47,696 | 1,739 | 380 | 1,437 | N/A |
| 9/30/2020 | 40,712 | 1,402 | 627 | 1,862 | N/A |
| 6/30/2020 | 39,617 | 1,378 | 974 | 2,011 | N/A |
| 3/31/2020 | 37,142 | 1,230 | 1,113 | 1,870 | N/A |
| 12/31/2019 | 37,204 | 1,262 | 1,752 | 2,426 | N/A |
| 9/30/2019 | 37,375 | 1,263 | -428 | 194 | N/A |
| 6/30/2019 | 35,350 | 1,177 | -264 | 290 | N/A |
| 3/31/2019 | 34,999 | 1,216 | -385 | 150 | N/A |
| 12/31/2018 | 33,550 | 1,180 | -719 | -219 | N/A |
| 9/30/2018 | 31,663 | 1,229 | -88 | 344 | N/A |
| 6/30/2018 | 29,619 | 1,150 | 169 | 510 | N/A |
| 3/31/2018 | 29,462 | 1,214 | 835 | 1,033 | N/A |
| 12/31/2017 | 29,706 | 1,314 | 1,076 | 1,239 | N/A |
| 9/30/2017 | 27,689 | 1,136 | N/A | 1,744 | N/A |
| 6/30/2017 | 26,950 | 1,097 | N/A | 1,587 | N/A |
| 3/31/2017 | 25,552 | 1,008 | N/A | 2,055 | N/A |
| 12/31/2016 | 23,984 | 806 | N/A | 1,600 | N/A |
| 9/30/2016 | 24,205 | 775 | N/A | 2,175 | N/A |
| 6/30/2016 | 24,794 | 736 | N/A | 2,266 | N/A |
| 3/31/2016 | 26,639 | 688 | N/A | 983 | N/A |
| 12/31/2015 | 27,260 | 761 | N/A | 846 | N/A |
| 9/30/2015 | 24,322 | 711 | N/A | -578 | N/A |
| 6/30/2015 | 21,314 | 646 | N/A | -444 | N/A |
| 3/31/2015 | 17,920 | 701 | N/A | 324 | N/A |
| 12/31/2014 | 15,873 | 701 | N/A | 963 | N/A |
| 9/30/2014 | 15,274 | 676 | N/A | 1,132 | N/A |
| 6/30/2014 | 14,744 | 643 | N/A | 948 | N/A |
| 3/31/2014 | 14,236 | 556 | N/A | 1,170 | N/A |
| 12/31/2013 | 14,272 | 564 | N/A | 1,326 | N/A |
| 9/30/2013 | 14,450 | 625 | N/A | 676 | N/A |
| 6/30/2013 | 14,031 | 680 | N/A | 790 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 601231's forecast earnings growth (22.5% per year) is above the savings rate (2.9%).
Earnings vs Market: 601231's earnings (22.5% per year) are forecast to grow slower than the CN market (23.9% per year).
High Growth Earnings: 601231's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 601231's revenue (8.3% per year) is forecast to grow slower than the CN market (14.3% per year).
High Growth Revenue: 601231's revenue (8.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 601231's Return on Equity is forecast to be low in 3 years time (16.1%).